Reversal of severe cholestasis caused by chronic graft-versus-host disease with the mars liver-support device [6]

Transplantation

Volumn 75, Issue 10, 2003, Pages 1766-1767

  Sen, Sambit ^a   Jalan, Rajiv ^a,c   Morris, Emma C ^b   Steiner, Christian ^a   Mackinnon, Stephen ^b   Williams, Roger ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ADULT; ALLOTRANSPLANTATION; ARTIFICIAL LIVER; CASE REPORT; CHOLESTASIS; CHRONIC GRAFT REJECTION; DISEASE SEVERITY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LETTER; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL;

CHOLESTASIS; GRAFT VS HOST DISEASE; HUMANS; LIVER, ARTIFICIAL; MALE; MIDDLE AGED;

EID: 0038392956     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000062538.32752.C1     Document Type: Letter

References (5)

1. Ferrara JLM, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991; 324: 667.
2. Liatsos C, Mehta AB, Potter M, et al. The hepatologist in the haematologists' camp. Br J Haematol 2001; 113: 567-578.
3. Wingard JR, Piantadosi S, Vogelsang GB, et al. Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood 1989; 74: 1428-1435.
4. Mitzner SR, Stange J, Klammt S, et al. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J Am Soc Nephrol 2001; 12(Suppl 17): S75-82.
5. Vora A, Monaghan J, Nuttall P, et al. Cytokine-mediated nitric oxide release- a common cytotoxic pathway in host-versus-graft and graftversus-host reactions? Bone Marrow Transplant 1997; 20: 385-389.